Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-03
DOI
10.1186/s12885-019-6387-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor immunotherapy: New aspects of natural killer cells
- (2018) Yangxi Li et al. Chinese Journal of Cancer Research
- Complex role of NK cells in regulation of oncolytic virus–bortezomib therapy
- (2018) Yangjin Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pediatric Cancer Immunotherapy: Opportunities and Challenges
- (2018) Mary Frances Wedekind et al. PEDIATRIC DRUGS
- An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma
- (2018) Bo Xu et al. NATURE BIOTECHNOLOGY
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Oncolytic Virotherapy for the Treatment of Malignant Glioma
- (2017) Paul M. Foreman et al. Neurotherapeutics
- NK cell-based immunotherapy for cancer
- (2017) Fang Fang et al. SEMINARS IN IMMUNOLOGY
- Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment
- (2017) Aiping Chen et al. Scientific Reports
- Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
- (2017) Jie Yin et al. Frontiers in Oncology
- Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
- (2016) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility
- (2015) P-Y Wang et al. GENE THERAPY
- Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
- (2015) Timothy P Cripe et al. MOLECULAR THERAPY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
- (2014) Fiona Errington et al. JOURNAL OF IMMUNOLOGY
- Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
- (2014) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- Primary resistance phenomena to oncolytic measles vaccine viruses
- (2013) MARKUS NOLL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68
- (2013) Klaas Ehrig et al. Journal of Translational Medicine
- Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
- (2013) S. Berchtold et al. JOURNAL OF VIROLOGY
- Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors
- (2013) Xueqing Lun et al. Molecular Oncology
- Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
- (2012) Robert A. Adair et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
- (2012) Christopher A Alvarez-Breckenridge et al. NATURE MEDICINE
- Natural killer cell lines in tumor immunotherapy
- (2012) Min Cheng et al. Frontiers of Medicine
- Kinetic Tracking of Therapy-Induced Senescence Using the Real-Time Cell Analyzer Single Plate System
- (2011) Timo Weiland et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
- (2011) Emilie P. Buddingh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts
- (2010) Pooja Hingorani et al. CANCER
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- Killing the Killer: Natural Killer Cells to Treat Ewing's Sarcoma
- (2010) Y.-O. Ahn et al. CLINICAL CANCER RESEARCH
- REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer
- (2010) C. Comins et al. CLINICAL CANCER RESEARCH
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program
- (2010) Christopher L. Morton et al. PEDIATRIC BLOOD & CANCER
- Regulation of human NK-cell cytokine and chemokine production by target cell recognition
- (2009) C. Fauriat et al. BLOOD
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects
- (2009) Yama A. Abassi et al. CHEMISTRY & BIOLOGY
- Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy
- (2009) Duck Cho et al. Korean Journal of Laboratory Medicine
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started